Pasithea Therapeutics (KTTA) Corporate Presentation from NobleCon18News and Market Data on Pasithea TherapeuticsNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.


Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News

9/17/2026
Consumer
Release – The Office Gurus Strengthens Executive Leadership Team to Accelerate Next Phase of Global Growth
The Office Gurus (TOG), a business segment of Superior Group of Companies, Inc. (NASDAQ: SGC), announced the appointments of Mark Lyndsell as Executive Vice President of Global Operations and Troy...
4 min read

9/17/2026
Healthcare
GeoVax Labs (GOVX) – MVA Technology Platform Produces New Vaccine For Ebola
BDBV Vaccine Construct Developed With GeoVax’s Proprietary Technology. GeoVax has developed a new vaccine construct against Bundibugyo virus (BDBV). This is the virus causing the Ebola Virus Disease (EVD) outbreak...
2 min read

9/17/2026
Natural Resources
First Phosphate Corp. (PHOS) – SERV Adds a Significant New Export Credit Agency (ECA) Financing Component
Swiss support adds another financing layer. First Phosphate has received a Letter of Support from Swiss Export Risk Insurance (SERV) for approximately US$212.5 million in potential financing tied to Swiss...
2 min read

9/17/2026
Natural Resources
Kodiak Copper Corp. (KDKCF) – Advancing a District-Scale Copper-Gold Porphyry Project in British Columbia
A large copper resource with room to grow. We have initiated coverage of Kodiak Copper Corp. with an Outperform rating and a price target of C$2.10, or approximately US$1.50 per...
2 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.